Add a listing
    Add a listing

    Vincere Biosciences

      Drugs to modulate mitophagy to treat disease. USP inhibitors

    General
    • Headquarters

      Cambridge, Massachusetts, United States

    • Founders & Team

      Andy Lee, Spring Behrouz

    • Year Founded

      2018

    • Number of employees

      10

    • Company type

      Private company

    • Funding stage

      Seed

    • Investors

      Alumni Ventures

    Technical Details
    • Aging Target

      Mitochondrial dysfunction

    • Disease indication

      Parkinson's

    • Product modality

      small molecule drugs

    About

    Vincere develops small molecule therapeutics to improve mitochondrial quality. Natural mechanisms of mitochondrial quality control decline with age, leading to the neurodegeneration seen in Parkinson's disease which affects 10 million patients worldwide.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In